CRASH-3 trial; Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo-controlled trial. ISRCTN15088122

Project Details

Short titleCRASH-3 trial; Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo-controlled trial. ISRCTN15088122
StatusFinished
Effective start/end date1/10/14 → 31/01/21

Funding

  • London School Of Hygiene And Tropical Medicine